NCT05785130

Brief Summary

Poor sleep quality is one of the most common problems among adult patients in the intensive care unit (ICU). The causes of sleep disturbance are complicated. Poor sleep quality can lead to negative consequences for patients' physical and mental health. Non-pharmacological interventions, such as white noise, have been recommended to increase the threshold level of sound during nighttime and achieve masking effects to improve subjective sleep quality. This study is a randomized controlled trial that compared two parallel patient groups.The hypothesis of this study is that white noise can improve sleep quality in adult ICU patients compared with conventional treatment group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 27, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

April 17, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 4, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2024

Completed
4 months until next milestone

Results Posted

Study results publicly available

March 17, 2025

Completed
Last Updated

March 17, 2025

Status Verified

March 1, 2025

Enrollment Period

1.3 years

First QC Date

March 14, 2023

Results QC Date

November 30, 2024

Last Update Submit

March 10, 2025

Conditions

Keywords

sleep qualitysleep disturbanceintensive care unitcritically ill patient

Outcome Measures

Primary Outcomes (1)

  • The Verran and Snyder-Halpern Sleep Scale Scores on Baseline, the First Intervention Day(T1), the Third Intervention Day(T2), and Follow up Two Days Later After Intervention (T3) Between Two Groups.

    Sleep quality is assessed using the Verran and Snyder-Halpern (VSH) Sleep Scale, a subjective sleep scale that contains three dimensions: sleep disturbance, sleep effectiveness, and sleep supplementation, with a total of 15 items. Scores are measured using a visual analogue scale, which is a 100mm horizontal line. The maximum score is 100, and the minimum score is 0. The total score of the VSH Sleep Scale (VSHSS) ranges from 0 to 1500. The subscales are combined by summing the individual scores for each item, and the total score is obtained by adding the scores from each of the subscales. The lower the score, the poorer the sleep quality. Outcomes were measured at baseline, the first intervention day (T1), the third intervention day (T2), and two days after the intervention (T3) for both groups.

    Baseline, 1st days, 3rd days and 5th days.

Study Arms (2)

white noise group

EXPERIMENTAL

Background noise at bedtime.

Other: white noise

conventional treatment group

NO INTERVENTION

Treatment as usual.

Interventions

Using sound machine for 3 days at bedtime for 7 hours(11p.m.- 6a.m.) in a decibel of 40-50.

white noise group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age must be greater than or equal to 20 years old.
  • Admitted to the ICU and have been intubated for at least 24 hours.
  • Aware of people, time, and place, and without hearing impairment.
  • Be able to communicate in writing.
  • The Glasgow Coma Scale score must be equal to or greater than 11, with a vocal response of 1 in the patient post-endotracheal tube placement.

You may not qualify if:

  • History of insomnia, Alzheimer's disease, or depression.
  • Routine use of sedative-hypnotic drugs (opioids, benzodiazepines, non-benzodiazepines, antihistamines, and melatonin) before admission.
  • Post-operation in the operating room before ICU admission.
  • ICDSC score of at least 4 or CAM-ICU positive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Kaohsiung City, 833401, Taiwan

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersParasomnias

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Results Point of Contact

Title
Ya-Ching, Nien
Organization
ChangGung Memorial Hospital

Study Officials

  • Ya-Ching Nien

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 14, 2023

First Posted

March 27, 2023

Study Start

April 17, 2023

Primary Completion

August 4, 2024

Study Completion

November 28, 2024

Last Updated

March 17, 2025

Results First Posted

March 17, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations